Federation des caisses Desjardins du Quebec’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $705 | Buy |
641
+500
| +355% | +$593 | ﹤0.01% | 2845 |
|
|
2026
Q1 | $245 | Hold |
141
| – | – | ﹤0.01% | 2866 |
|
|
2025
Q4 | $245 | Hold |
141
| – | – | ﹤0.01% | 2774 |
|
|
2025
Q3 | $330 | Sell |
141
-166
| -54% | -$318 | ﹤0.01% | 2755 |
|
|
2025
Q2 | $625 | Hold |
307
| – | – | ﹤0.01% | 2550 |
|
|
2025
Q1 | $500 | Sell |
307
-133
| -30% | -$267 | ﹤0.01% | 2486 |
|
|
2024
Q4 | $805 | Hold |
440
| – | – | ﹤0.01% | 2343 |
|
|
2024
Q3 | $2.54K | Hold |
440
| – | – | ﹤0.01% | 2194 |
|
|
2024
Q2 | $3.56K | Sell |
440
-250
| -36% | -$2.63K | ﹤0.01% | 2026 |
|
|
2024
Q1 | $9.58K | Sell |
690
-2
| -0.3% | -$17 | ﹤0.01% | 1826 |
|
|
2023
Q4 | $4.23K | Sell |
692
-141
| -17% | -$696 | ﹤0.01% | 1946 |
|
|
2023
Q3 | $3.89K | Sell |
833
-84
| -9% | -$464 | ﹤0.01% | 1969 |
|
|
2023
Q2 | $4.92K | Buy |
917
+84
| +10% | +$677 | ﹤0.01% | 1914 |
|
|
2023
Q1 | $8.2K | Buy |
833
+41
| +5% | +$699 | ﹤0.01% | 1811 |
|
|
2022
Q4 | $14.8K | Sell |
792
-41
| -5% | -$929 | ﹤0.01% | 1769 |
|
|
2022
Q3 | $17.3K | Hold |
833
| – | – | ﹤0.01% | 1772 |
|
|
2022
Q2 | $17.3K | Sell |
833
-9
| -1% | -$254 | ﹤0.01% | 1809 |
|
|
2022
Q1 | $36.3K | Hold |
842
| – | – | ﹤0.01% | 1674 |
|
|
2021
Q4 | $50.4K | Sell |
842
-33
| -4% | -$2.64K | ﹤0.01% | 1593 |
|
|
2021
Q3 | $75.2K | Hold |
875
| – | – | ﹤0.01% | 1481 |
|
|
2021
Q2 | $97.3K | Hold |
875
| – | – | ﹤0.01% | 1428 |
|
|
2021
Q1 | $97.4K | Sell |
875
-1,258
| -59% | -$165K | ﹤0.01% | 1350 |
|
|
2020
Q4 | $227K | Sell |
2,133
-134
| -6% | -$17.8K | ﹤0.01% | 1028 |
|
|
2020
Q3 | $316K | Buy |
2,267
+1,517
| +202% | +$316K | ﹤0.01% | 759 |
|
|
2020
Q2 | $243K | Sell |
750
-108
| -13% | -$17.3K | ﹤0.01% | 798 |
|
|
2020
Q1 | $76.6K | Buy |
858
+612
| +249% | +$37.7K | ﹤0.01% | 1121 |
|
|
2019
Q4 | $9.73K | Hold |
246
| – | – | ﹤0.01% | 1894 |
|
|
2019
Q3 | $6.05K | Hold |
246
| – | – | ﹤0.01% | 1919 |
|
|
2019
Q2 | $8.67K | Hold |
246
| – | – | ﹤0.01% | 1884 |
|
|
2019
Q1 | $11K | Hold |
246
| – | – | ﹤0.01% | 1648 |
|
|
2018
Q4 | $11.8K | Hold |
246
| – | – | ﹤0.01% | 1583 |
|
|
2018
Q3 | $16.4K | Hold |
246
| – | – | ﹤0.01% | 1608 |
|
|
2018
Q2 | $11.6K | Hold |
246
| – | – | ﹤0.01% | 1717 |
|
|
2018
Q1 | $13.9K | Hold |
246
| – | – | ﹤0.01% | 1635 |
|
|
2017
Q4 | $12.2K | Hold |
246
| – | – | ﹤0.01% | 1676 |
|
|
2017
Q3 | $18.7K | Hold |
246
| – | – | ﹤0.01% | 1541 |
|
|
2017
Q2 | $23.1K | Buy |
+246
| New | +$21K | ﹤0.01% | 1549 |
|
Other funds holding INO
JT
BCM
ACM
EP
Federation des caisses Desjardins du Quebec's INO Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec increased its Inovio Pharmaceuticals (INO) stake by 355% in Q2 2026, buying an estimated $593 and bringing the position to 641 shares worth $705. The position accounts for ﹤0.01% of the portfolio, ranked #2845.
Federation des caisses Desjardins du Quebec first reported a position in INO in Q2 2017 and has held it in 37 quarters since. The position peaked at $316K in Q3 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 641 shares of Inovio Pharmaceuticals worth $705 as of Q2 2026.
- Federation des caisses Desjardins du Quebec bought 500 Inovio Pharmaceuticals shares in Q2 2026, an estimated $593.
- Inovio Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2845 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Inovio Pharmaceuticals in Q2 2017 and has held it in 37 quarters since.
- Federation des caisses Desjardins du Quebec's Inovio Pharmaceuticals position peaked at $316K in Q3 2020.
- 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.